Alfresa Holdings Corporation

TSE:2784 Stock Report

Market Cap: JP¥402.7b

Alfresa Holdings Past Earnings Performance

Past criteria checks 2/6

Alfresa Holdings's earnings have been declining at an average annual rate of -4.6%, while the Healthcare industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 1.5% per year. Alfresa Holdings's return on equity is 6.4%, and it has net margins of 1.1%.

Key information

-4.6%

Earnings growth rate

-2.0%

EPS growth rate

Healthcare Industry Growth7.9%
Revenue growth rate1.5%
Return on equity6.4%
Net Margin1.1%
Next Earnings Update10 Feb 2025

Recent past performance updates

Alfresa Holdings' (TSE:2784) Solid Earnings May Rest On Weak Foundations

Nov 21
Alfresa Holdings' (TSE:2784) Solid Earnings May Rest On Weak Foundations

Alfresa Holdings' (TSE:2784) Earnings Offer More Than Meets The Eye

May 22
Alfresa Holdings' (TSE:2784) Earnings Offer More Than Meets The Eye

Recent updates

Alfresa Holdings' (TSE:2784) Solid Earnings May Rest On Weak Foundations

Nov 21
Alfresa Holdings' (TSE:2784) Solid Earnings May Rest On Weak Foundations

Here's What Analysts Are Forecasting For Alfresa Holdings Corporation (TSE:2784) After Its Half-Year Results

Nov 11
Here's What Analysts Are Forecasting For Alfresa Holdings Corporation (TSE:2784) After Its Half-Year Results

Does Alfresa Holdings (TSE:2784) Deserve A Spot On Your Watchlist?

Oct 22
Does Alfresa Holdings (TSE:2784) Deserve A Spot On Your Watchlist?

The Returns On Capital At Alfresa Holdings (TSE:2784) Don't Inspire Confidence

Oct 08
The Returns On Capital At Alfresa Holdings (TSE:2784) Don't Inspire Confidence

Investor Optimism Abounds Alfresa Holdings Corporation (TSE:2784) But Growth Is Lacking

Jul 30
Investor Optimism Abounds Alfresa Holdings Corporation (TSE:2784) But Growth Is Lacking

Alfresa Holdings (TSE:2784) Seems To Use Debt Rather Sparingly

Jul 12
Alfresa Holdings (TSE:2784) Seems To Use Debt Rather Sparingly

We Ran A Stock Scan For Earnings Growth And Alfresa Holdings (TSE:2784) Passed With Ease

Jun 25
We Ran A Stock Scan For Earnings Growth And Alfresa Holdings (TSE:2784) Passed With Ease

Alfresa Holdings (TSE:2784) Will Be Looking To Turn Around Its Returns

Jun 06
Alfresa Holdings (TSE:2784) Will Be Looking To Turn Around Its Returns

Alfresa Holdings' (TSE:2784) Earnings Offer More Than Meets The Eye

May 22
Alfresa Holdings' (TSE:2784) Earnings Offer More Than Meets The Eye

Is There An Opportunity With Alfresa Holdings Corporation's (TSE:2784) 32% Undervaluation?

Apr 19
Is There An Opportunity With Alfresa Holdings Corporation's (TSE:2784) 32% Undervaluation?

Alfresa Holdings' (TSE:2784) Shareholders Will Receive A Bigger Dividend Than Last Year

Mar 12
Alfresa Holdings' (TSE:2784) Shareholders Will Receive A Bigger Dividend Than Last Year

Alfresa Holdings' (TSE:2784) Dividend Will Be Increased To ¥35.00

Feb 27
Alfresa Holdings' (TSE:2784) Dividend Will Be Increased To ¥35.00

Revenue & Expenses Breakdown

How Alfresa Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

TSE:2784 Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 242,886,99931,773161,9850
30 Jun 242,871,80929,940159,6470
31 Mar 242,858,50029,558157,8980
31 Dec 232,827,93731,835154,7400
30 Sep 232,791,50630,635154,5270
30 Jun 232,748,00327,711154,6860
31 Mar 232,696,06925,786152,1110
31 Dec 222,668,18228,250153,6350
30 Sep 222,629,35632,195151,8130
30 Jun 222,599,17931,064149,1060
31 Mar 222,585,64332,182149,2190
31 Dec 212,583,10224,171147,5190
30 Sep 212,596,74920,392147,6070
30 Jun 212,596,74422,032147,2060
31 Mar 212,603,16924,501146,7450
31 Dec 202,621,12031,362148,6720
30 Sep 202,626,48233,241149,7250
30 Jun 202,671,48938,095151,1380
31 Mar 202,698,51140,273151,6020
31 Dec 192,700,67235,188153,3100
30 Sep 192,709,85843,046152,1790
30 Jun 192,653,71941,242150,5580
31 Mar 192,640,51141,699149,7260
31 Dec 182,630,78545,235147,5920
30 Sep 182,620,80139,438146,7230
30 Jun 182,620,05538,110146,1460
31 Mar 182,602,91735,589145,1140
31 Dec 172,592,86533,125143,7630
30 Sep 172,572,58731,359142,8740
30 Jun 172,553,57127,926142,3670
31 Mar 172,551,80130,893142,6070
31 Dec 162,556,53833,200144,8170
30 Sep 162,573,25634,214145,1120
30 Jun 162,585,84037,564145,1170
31 Mar 162,576,40534,975144,6880
31 Dec 152,547,70928,728139,2800
30 Sep 152,509,45526,946136,2460
30 Jun 152,471,15323,087133,3210
31 Mar 152,421,16222,922129,8950
31 Dec 142,446,23025,212130,3110
30 Sep 142,456,58925,040130,1420
30 Jun 142,474,07026,733129,5670
31 Mar 142,504,50425,566129,4080
31 Dec 132,463,92221,783128,2150

Quality Earnings: 2784 has a large one-off gain of ¥8.1B impacting its last 12 months of financial results to 30th September, 2024.

Growing Profit Margin: 2784's current net profit margins (1.1%) are higher than last year (1.1%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 2784's earnings have declined by 4.6% per year over the past 5 years.

Accelerating Growth: 2784's earnings growth over the past year (3.7%) exceeds its 5-year average (-4.6% per year).

Earnings vs Industry: 2784 earnings growth over the past year (3.7%) did not outperform the Healthcare industry 8.3%.

Return on Equity

High ROE: 2784's Return on Equity (6.4%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 03:01
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Alfresa Holdings Corporation is covered by 9 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Toshihide YodaBarclays
Ritsuo WatanabeBofA Global Research
Yuki YamazakiDaiwa Securities Co. Ltd.